Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (99)	12/19/1998 6:51:00 PM
From: Vip	Read Replies (1) \| Respond to of 395

Hi Richard: I like the potential $10 million in revenue. There has been continued institutional investment. I wish the good news would be reflected in the stock price. Does anyone have an opinion on the company's cash position? Vip

To: scaram(o)uche who wrote (99)	3/10/1999 9:33:00 AM
From: LLCF	Read Replies (2) \| Respond to of 395

Front page new on RGEN in WSJ.... article on Autism.. also company press release: biz.yahoo.com Very interesting article. Anecdotal evidence of autism being a gastric disorder is becoming compelling... HOWEVER IMO this will not be "cure", or even long term therapy, but a potential supplement to be followed up diet changes. There is also anecdotal evidence that food allergies, followed by the taking of antibiotics to treat ensuing problems cause the gastric problems originally. DAK